dsp 4 has been researched along with selegiline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeLanney, LE; Finnegan, KT; Irwin, I; Langston, JW; Skratt, JJ | 1 |
| Gibson, CJ | 1 |
| Yu, PH; Zhang, X; Zuo, DM | 1 |
| Boulton, AA; Davis, BA; Fang, J; Yu, PH | 1 |
| Finnegan, KT | 1 |
| Yu, PH; Zhang, X | 1 |
| Boulton, AA; Davis, BA; Yu, PH; Zhang, X; Zuo, DM | 1 |
| Lengyel, J; Magyar, K; Szatmáry, I; Szende, B; Tarczali, J | 1 |
| Haberle, D; Halász, AS; Magyar, K; Szökö, E | 1 |
1 review(s) available for dsp 4 and selegiline
| Article | Year |
|---|---|
The neuroprotective and neuronal rescue effects of (-)-deprenyl.
Topics: Animals; Antiparkinson Agents; Benzylamines; Biotransformation; Brain; Humans; Melanoma; Neurons; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Rats; Selegiline; Tissue Distribution; Tumor Cells, Cultured | 1998 |
8 other study(ies) available for dsp 4 and selegiline
| Article | Year |
|---|---|
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
Topics: Allyl Compounds; Animals; Benzylamines; Butylamines; Hippocampus; Kinetics; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nervous System Diseases; Norepinephrine; Selegiline | 1990 |
Inhibition of MAO B, but not MAO A, blocks DSP-4 toxicity on central NE neurons.
Topics: Animals; Benzylamines; Brain Chemistry; Hypothalamus; Male; Methoxyhydroxyphenylglycol; Mice; Monoamine Oxidase Inhibitors; Neurotoxins; Norepinephrine; Pargyline; Selegiline | 1987 |
Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus.
Topics: Adrenergic Agents; Animals; Benzylamines; Locus Coeruleus; Male; Nerve Degeneration; Neurons; Norepinephrine; Propylamines; Rats; Rats, Wistar; Selegiline | 1995 |
Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4-induced noradrenaline depletion in the mouse hippocampus.
Topics: Animals; Benzylamines; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Hippocampus; Male; Mice; Monoamine Oxidase Inhibitors; Neurons; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pargyline; Phenelzine; Propylamines; Selegiline; Time Factors | 1994 |
Neurotoxins and monoamine oxidase inhibition: new aspects.
Topics: Animals; Benzylamines; Brain; Dose-Response Relationship, Drug; Isoenzymes; Male; Mice; Mice, Inbred BALB C; Monoamine Oxidase; Nerve Degeneration; Neurons; Neurotoxins; Norepinephrine; Selegiline | 1993 |
Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl.
Topics: Animals; Benzylamines; Dentate Gyrus; Enzyme Inhibitors; Histocytochemistry; Male; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Propylamines; Rats; Rats, Wistar; Selegiline | 1995 |
Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals.
Topics: Animals; Axons; Benzylamines; Immunohistochemistry; Male; Monoamine Oxidase Inhibitors; Nerve Degeneration; Nerve Endings; Neuroprotective Agents; Neurotoxins; Norepinephrine; Propylamines; Rats; Rats, Wistar; Reference Values; Selegiline; Sensitivity and Specificity | 1996 |
The effect of low oral doses of (-)-deprenyl and its metabolites on DSP-4 toxicity.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Benzylamines; Dose-Response Relationship, Drug; Drug Administration Schedule; Hippocampus; Injections, Intraperitoneal; Male; Mice; Monoamine Oxidase Inhibitors; Neurotransmitter Uptake Inhibitors; Norepinephrine; Selegiline | 2001 |